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Renal ammonia metabolism in humans with chronic potassium deple-
tion. Renal ammonia production and distribution and ammonia precur-
sor utilization were evaluated in eight patients with chronic potassium
depletion (CPD) and aldosterone-producing adenoma and in 20 con-
trols. In CPD, urinary ammonia excretion and ammonia added to renal
venous blood were about twofold higher than in controls; thus, total
ammonia production was significantly augmented (88.0 10.3 mol/
mm 1.73 m2 vs. 45.0 2.6 in controls). Total ammonia production was
inversely correlated with serum potassium and directly correlated with
urine flow. Stepwise multiple regression analysis showed that both
factors, mainly serum potassium, significantly influence ammonia pro-
duction and account for 61.4% of variations in ammonia production.
Renal extraction of glutamine was significantly increased (56.6 5.9
smol/min. 1.73 m2 vs. 34.6 3.1 in controls), and this could account
for ammonia production. The ratio of urinary ammonia excretion to
total ammonia production, an index of the intrarenal ammonia distri-
bution, was similar in patients and controls, and was significantly
correlated with urine pH and true renal blood flow (RBF). Stepwise
multiple regression analysis showed that RBF, urine pH and urine flow
also significantly affected ammonia distribution. However, these factors
accounted for only 41.7% of variations in intrarenal ammonia partition,
urine pH having a minor role. We conclude that in patients with CPD
other factors besides urine pH, urine flow and RBF intervene in the
ammonia partition between urine and blood.
Systemic potassium balance and acid-base regulation are
tightly linked, as indicated by the effects of alterations in
potassium homeostasis on urinary ammonia and net acid excre-
tion observed both in humans and experimental animals [1]. In
humans, potassium depletion due either to gastrointestinal and
renal loss or reduced potassium intake or hypermineralcorti-
coidism is associated with metabolic alkalosis and an increase
in urinary ammonia and net acid excretion [1—4]. Conversely,
chronic potassium surfeit decreases urinary ammonia excretion
[1].
Despite a number of studies on urinary ammonia excretion in
potassium depleted animals and humans [1], information on the
relationship between potassium depletion and renal ammonia
metabolism is still incomplete; furthermore, species differences
make it difficult to extrapolate results obtained in animals to
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humans. Renal ammonia metabolism deals with a sequence o1
steps, encompassing ammonia synthesis and substrate utiliza
tion, ammonia transport from the site of formation to the fina
urine and blood, as well as the factors which influence eaci
individual step [5—9]. Recent investigations have brought aboui
substantial advances in the knowledge of ammonia transport ii
different nephron segments in potassium depletion [10—151. Yet
in vivo studies are necessary to achieve an overall view of rena
ammonia metabolism.
The present study was carried out with the purpose 01
evaluating total renal ammonia production and ammoniagen
substrate utilization in patients with chronic potassium deple
tion (CPD) and metabolic alkalosis due to aldosterone-produc.
ing adenoma. The study was performed by measuring ammoni
excreted with urine and that released into the renal veins, anc
glutamine, glutamate and alanine exchange across the kidney
The individual role of some factors which can affect productior
of ammonia and its distribution between urine and renal venom
blood, such as plasma potassium concentration, acid-base
parameters in blood and urine, true renal blood flow (RBF), and
urine flow, have also been evaluated. In the present paper, the
term ammonia refers to the sum of ammonium ions and free
ammonia base. The individual chemical formulas (NH4 and
NH3) are used to indicate the individual species.
Methods
Patients
During the last 12 years eight hypertensive patients, six men
and two women, aged 43 3 years, who were diagnosed with
hypokalemia and suspected primary aldosteronism were stud-
ied. Upon admission to the hospital their mean blood pressure
ranged from 130 to 145 mm Hg. All patients had serum
potassium levels lower than 2.4 mmollliter. Serum sodium was
145 5.4 mmoL/liter, arterial bicarbonate 29.8 1.7 mmollliter
and glucose 5.2 0,3 mmollliter. Electrocardiographic changes
consistent with hypokalemia were observed in all patients.
They had elevated urinary aldosterone excretion (mean 39 7
p.g/24 hr) and abnormally low recumbent plasma renin activity
(0.3 0.1 nglmllhr). Patients had to undergo an adrenal vein
catheterization for discriminating adenoma from bilateral hy-
perplasia or for presurgical localization of the aldosterone-
producing adenoma, when computerized tomography was not
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yet available or because adrenal visualization was unsatisfac-
tory. The final diagnosis was aldosterone-producing adenoma.
The control group consisted of 20 patients, 15 men and five
women, aged 36 3 years. In eight patients with cardiac
valvular disease, a right-sided cardiac catheterization was con-
sidered necessary for diagnostic hemodynamic evaluation.
Twelve patients had arterial hypertension with mean blood
pressure ranging from 135 to 155 mm Hg. In these patients a
renal vein catheterization had to be performed to determine
plasma renin activity; the final diagnosis was benign essential
hypertension. Routine laboratory tests, renal function, acid-
base, and electrolyte measurements were normal. Some data
obtained in nine out of 20 controls were also reported elsewhere
[16, 171.
Neither group of patients had a history of evidence of
gastrointestinal or hepatic disease, congestive heart failure, or
diabetes mellitus. After admission, both patients and controls
were placed on a constant diet containing 30 to 35 kcal, and 0.7
to 0.85 g of protein/kg body weight, with 110 to 130 mEq sodium
and 50 to 80 mEq potassium daily for at least six days. In
patients with CPD, potassium levels did not change significantly
during the above reported diet. Medications, if any, were
discontinued at least 10 days before the study.
The patients were informed on the nature, purpose, proce-
dure and possible risks before their voluntary consent was
obtained. Procedures followed were in accord with the Helsinki
Declaration.
Procedure
Renal ammoniagenesis and intrarenal ammonia distribution
were studied by the arterial-renal venous difference technique
[16, 17]. The patients were studied at rest, after a 12 to 14 hour
fast. A Teflon catheter was inserted percutaneously into a radial
artery. A Cobra No 6S or 7S catheter (USCI Billerica, Massa-
chusetts, USA) was inserted into a renal vein either directly or
after the diagnostic procedure was completed. The position of
the catheter was ascertained visually with image intensification
before each blood withdrawal. Arterial blood pressure and
electrocardiogram were continuously monitored during the
study.
An intravenous infusion of Na thiosuiphate and Na para-
aminohippurate (PAH) was started after the administration of a
priming dose and maintained at a constant rate (Na thiosulphate
5 prnollkglmin, and PAH 1 smo1Ikg/min) and two or three
sequential clearance periods of 20 minutes each were obtained.
The correct position of the catheter in the renal veins was
verified by calculating the renal extraction of PAH and oxygen.
During each clearance period at least two sets of blood samples
were obtained simultaneously from a peripheral artery and a
renal vein for the measurement of arterial-renal venous differ-
ences of ammonia and amino acids.
Blood was withdrawn by heparinized syringes kept in ice.
During the study urine was collected via a cannula under
mineral oil in bottles that contained thymol.
Analytical methods
Methods employed for blood sample preparation, determina-
tion of glomerular filtration rate (GFR), RBF and acid-base
parameters, and measurement of ammonia and amino acids in
whole blood and urine, and titratable acidity in urine have been
extensively reported elsewhere [16—18]. With regard to GFR
measurement, Na thiosulphate methods were used here as in
similar studies [16, 171; this method provides results strictly
comparable with those obtained by the inulin clearance [191.
Ammonia was determined according to the Chaney and
Marbach method [20] modified in our laboratory [18]. Glu-
tamine was determined enzymatically according to the Lund
method [21], adapted for fluorometer measurements (Farrand A
4, Farrand Optical Co., Valhalla, New York, USA) [16, 17].
Glutamate was determined with the method of Graham and
Aprison [22]. Alanine was measured by ion exchange chroma-
tography [18] (Multichrom B amino acid analyzer, Beckman
Instruments, Fullerton, California, USA; or 3A29 amino acid
analyzer, Carlo Erba, Milano, Italy).
Na thiosulphate and PAH levels in plasma and urine were
determined according to Brun [23] and Smith, Goldring and
Chasis [24], respectively.
Blood and urine pH and PaCO2 were estimated at 37°C with
PHM 72/BMS 3 apparatus (Radiometer Co., Copenhagen,
Denmark). Blood HC03 was calculated using the Henderson-
Hasselbalch equation. Urine titratable acidity was measured by
titration with 0.1 mollliter NaOH up to arterial pH. Sa02 was
measured with an Hellige oximeter (American Optical Corp.
Scientific Instrument Div., Buffalo, New York, USA). Hema-
tocrit was determined by a microcapillary procedure.
Calculations
Renal arterial plasma flow was calculated from clearance and
extraction of PAH using the equation of Wolf [25]. RBF was
calculated from renal plasma flow and arterial hematocrit.
The total ammonia production was obtained by summing the
values for renal venous ammonia release and urine ammonia
excretion.
Net extraction (+) or net release (—) of amino acids by the
kidney were calculated by the following formula:
M = [(Fa x Sa) — Sv(Fa — Fu)] — (Fu x Su),
where: M is net uptake or release (moUmin 1.73 m2), Fa is
renal arterial blood flow (mllmin 1.73 m2), Fu is urinary flow
(mi/mm. 1.73 m2), Sa is arterial level of metabolite (molIml),
Sv is renal venous level of metabolite (molIml), and Su is
urinary level of metabolite (mol/ml).
Patients with CPD and controls were compared by analysis of
variance by using a completely randomized design; a random-
ized block design was applied to the analysis of variance for the
paired data [26]. Analysis of simple regression and correlation
[26] was used to evaluate relationships of total ammonia pro-
duction and the ratio of urinary ammonia excretion to produced
ammonia (dependent variables) with serum potassium levels,
acid-base parameters in arterial blood and urine, urine flow and
RBF. Stepwise multiple regression analysis [27] was used in
order to discover: a) which independent variables were signif-
icantly related to the dependent variables when the contribution
of other independent variables was factored out; b) which
proportion of variations in dependent variables was accounted
for by each independent variable and by the model. Indepen-
dent variables were adequately transformed in order to linearize
their relationships with dependent variables. Values are given
as mean SEM.
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Table 1. Major clinical data for patients with chronic potassium depletion and for controls
Serum Urine Titratable Net acid Arterial
Body [K] Duration of GFR RBF flow acidity excretion Urine Arterial [HC031
Age surface mmoll K depletion mmo!/
Patients years Sex m2 liter days mi/mm 1.73 m2 jsEq/min 1.73 m2 pH liter
Chronic potassium depletion (8)
48 M 1.73 1.8 >30 103 800 3.34 3.1 22.0 7.39 7.55 38.4
2 48 M 2.02 2.8 7 155 1134 2.68 14.8 41.4 7.02 7.42 25.9
3 48 M 1.64 2.2 >30 165 1303 5.18 4.6 18.7 7.31 7.47 31.2
4 30 M 1.76 2.1 >30 82 728 3.37 13.1 28.2 6.44 7.46 26.8
5 42 F 1.56 2.4 >30 103 981 7.77 0.4 12.6 7.10 7.51 28.0
6 40 F 1.68 2.5 >30 114 1134 6.08 9.0 29.9 6.84 7.50 28.0
7 54 M 2.10 2.8 13 96 1035 9.61 18.2 50.1 6.65 7.53 27.6
8 31 M 2.08 1.9 >10 152 802 3.94 9.1 30.1 6.96 7.46 26.3
Mean + 43 2F/6M 1.82 2.3 — 121 990 5.25 9.0 30.0 6.97 7.48 29.0
SEM 71b
Controls (20)
Mean ÷ 36 5F/15M 1.77 4.0 — 140 1205 2.23 15.0 36.7 5.74 7,41 22.9
SEM ±3 ±0.04 ±0.1 ±4 ±38 ±0.22 ±2.0 ±5.0 ±0.15 ±0.01 ±0.4
Abbreviations are: GFR, glomerular filtration rate; RBF, true renal blood flow.
Significance of difference from the corresponding value in controls: a p < 0.025, b p < 0.01; C P < 0.001
Table 2. Renal ammoniagenesis in patients with chronic potassium depletion (CPD) and in controls
Total Urinary 01
Total Gin
Urinary Ammonia added ammonia Renal vein ammonia extraction
ammonia
fi1ter1
ammonia to renal veins production ammonia Total pmol/min Gin N mitt GIn filtered-
prnol/rnin 1.73 m2 mo!/!iter ammonia 1.73 m2 extraction 1.73 m2 GIn extracted
CPD (8) 46.3 ± 6.0" 41.7 ± 6.9a 88.0 ± 10.3" 96.9 ± 95 0.532 ± 0.040 56.6 ± 59 0.81 ± 0.10 63.8 ± 10.1 7.2 ± 81b
Controls (20) 23.4 ± 1.8 21.6 ± 1.6 45.0 ± 2.6 62.7 ± 4.0 0.520 ± 0.023 34.6 ± 3.1 0.74 ± 0.07 76.2 ± 3.3 41.7 ± 4,2
Significance of difference from the corresponding value in controls: a p <0.005; b P < 0.001
Results
Major clinical data, GRF, RBF, and acid-base parameters in
blood and urine at the moment of the study are reported in
Table 1. Patients had severe hypokalemia (2.3 ± 0.1 mmollliter)
for at least seven days. GFR and RBF were significantly lower
than in controls even if in the normal range. Urine pH was
significantly increased and close to 7.0, whereas titratable
acidity and net acid excretion were slightly diminished. They
had an overt metabolic alkalosis.
Data regarding renal ammonia and glutamine metabolism are
reported in Table 2. In patients, urinary ammonia excretion was
about twofold higher than in controls. Also the amount of
ammonia added to renal venous blood increased almost two-
fold. Accordingly, total renal ammonia production was signifi-
cantly augmented in patients in comparison with controls (88.0
± 10.3 prnol/min. 1.73 m2 vs. 45.0 ± 2.6, P <0.001). Ammonia
levels in renal venous blood were significantly increased in
patients. Total ammonia production was inversely correlated
with serum potassium concentration (P < 0.0001; Fig. 1) and
directly nonlinearly correlated with urine flow (P < 0.001). The
stepwise multiple regression analysis has shown that only two
factors appear to be significantly determinants of total ammonia
production in CPD (Table 3). Serum potassium concentration
accounts for the 56.4% of variations in ammonia production.
Urine flow has a minor even if significant role. Together, these
two factors account for 61.4% of variations in ammonia pro-
duction. The multiple regression equation is:
total amonia production = 78.974 — 19.386 [K +
+ 36.723 urine flow0280
In patients, renal extraction of glutamine was significantly
increased in comparison with controls (56.6 ± 5.9 p.mol/
mm 1.73 m2 vs. 34.6 ± 3.1 in controls, P < 0.005; Table 2).
The ratio of produced ammonia to N contained in extracted
glutamine was similar in the two groups. Total ammonia pro-
duction was directly correlated with glutamine extraction (r =
0.583; P < 0.001). Furthermore, glutamine levels in arterial
blood in patients and controls were strictly comparable (511 ±
38 mol/liter vs. 516 ± 14 in controls) as well as the amount of
filtered glutamine. The difference between the amount of glu-
tamine filtered and that of glutamine extracted was significantly
lower in patients. Finally, the rates of renal release of glutamate
and alanine were similar in patients and in controls, that is, the
release of glutamate was 4.5 ± 2.3 versus 3.1 ± 1.0 tmoU
mm 1.73 m2 in controls, and that of alanine was 10.8 ± 3.4
versus 15.2 ± 4.4 mol/min 1.73 m2 in controls.
The distribution of produced ammonia between urine and
renal venous blood, expressed as the ratio of urinary ammonia






Determinants of renal ammonia production in chronic
depletion using stepwise multiple regression analysis
Variable
Regression Partial Model
coefficient r2 P r2 P
Serum [K] —19.386 0.564 <0.0002 0.564 <0.0001
Urine flowa +36.723 0.050 <0.02 0.614 <0.0001
a Urine flow was transformed as: urine flow0280
2). The ratio was individually related with a nonlinear trend to
urinary pH (Fig. 2) and RBF (P < 0.05). Table 4 reports major
determinants of the distribution of produced ammonia between
urine and blood in CPD detected by the stepwise multiple
regression analysis. RBF, urine pH and urine flow significantly
affected ammonia distribution, together accounting for 41.6% of
variations of ammonia distribution. Among the determinants,
RBF had the major role (27.8%), whereas urine pH and urine
flow played a minor part. The multiple regression equation is:
urinary ammonia e xcretionltotal ammonia production =
0.609 — 0.396 e41827 (RBF — 1527)
— 0.000413pHu3'8° + 0.0185 urine flow
Discussion
Renal ammonia production and glutamine utilization
This study demonstrates that in patients with CPD and
primary aldosteronism, total renal ammonia production is
markedly increased, and that the severity of potassium deple-
tion modulates the ammoniagenic response. In patients with
CPD studied here, ECG changes indicate the existence of cell
potassium depletion; in addition, the degree of the hypokalemia
on the basis of two different methods of estimation [28] suggests
a potassium deficit of about 600 mEq. While it is well proven
that potassium depletion enhances renal ammoniagenesis in
vitro [1], only two studies deal with ammonia production in vivo
[29, 30]. An increased ammonia formation has been observed in
rats [29]. As with humans, the occurrence of an increased renal
ammoniagenesis in potassium depletion has been claimed only
on the basis of a study in cirrhotic patients with induced
metabolic acidosis in whom acute potassium depletion was
elicited by a mercurial diuretic [30].
The mechanisms responsible for the increased ammoniagene-
sis in CPD are, so far, poorly understood. An increased
intracellular concentration of hydrogen ions replacing the cel-
lular potassium losses has been commonly hypothesized [1, 31].
Even if there is good evidence that in potassium depletion the
intracellular pH is decreased in skeletal muscle [29], the few
studies on intracellular pH of tubule cells provide conflicting
results [32—34]. The decreased intracellular pH would stimulate
ammonia production at the nephron proximal site, analogously
to chronic metabolic acidosis. The observation that sodium
bicarbonate given to rats with CPD depresses renal ammonia-
genesis supports the role of intracellular pH in the increased
ammoniagenesis [29]. Also the role of low extracellular potas-
sium level per se in ammonia production by renal tissue is
controversial [11, 35]. It has been observed that aldosterone
stimulates ammonia synthesis in the perfused rat kidney inde-
pendently of alterations in potassium balance [36]. However, in
intact animals the administration of mineralcorticoids is fol-
lowed by both increased ammonia excretion and potassium
depletion [37, 38]. Accordingly, if and to what extent the
increased aldosterone production contributes to the altered
ammoniagenesis in patients with CPD here reported is uncer-
tain. Reasonably, results obtained in this condition can be
extended to patients with CPD associated with extracellular
volume depletion and secondary aldosteronism. An interesting
finding in the present study is the role of urine flow as a stimulus
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Fig. 1. Relationships between total renal
ammonia production and serum [K] in 8
patients with chronic potassium depletion (solid
squares) and in 20 controls (open squares). Y =




1.8 2.8 3.8 4.8
Serum [K[, mmol/Iiter
Fig. 2. Relationships between the ratio of
urinary ammonia excretion to total ammonia
production and urine pH in 8 patients with
chronic potassium depletion (solid squares) and
in 20 controls (open squares). Y = 0.630 —
O.000294x3'80; P < 0.05.
Table 4. Determinants of the distribution of produced ammonia between urine and renal venous blood (urinary ammonia exc








—0.396 0.278 <0.008 0.278
—0.000413 0.051 <0.005 0.329




a RBF was transformed as: e418274 (RBF — 1527.2)
Urine pH was transformed as: urine pH3'8°
regression analysis. It is possible that in this condition, as in
24-hour metabolic acidosis [17], the increased urine flow and
the consequent enhanced wash-out of ammonia at the luminal
cell surface are effective in stimulating renal ammonia produc-
tion.
It is well known that glutamine is the major substrate utilized
by the kidney for ammonia formation in normal acid-base
balance and metabolic acidosis in humans, as well as in animals
[5, 7, 39]. However, in humans in the early phase of metabolic
acidosis [17] and in chronic renal failure [16], other substrates in
addition to glutamine are utilized for ammoniagenesis. Results
obtained in this study show that in patients renal glutamine
extraction increases so much as to account for total ammonia
production. In fact, the ratio of produced ammonia to N
contained in extracted glutamine is similar in patients and
controls (Table 2); furthermore, ammonia formation and glu-
tamine extraction are strictly correlated. By comparing the
amount of glutarnine extracted with that filtered, it can be
hypothesized that glutamine utilized for the increased ammonia
production is supplied to tubular cells by glomerular filtrate.
However, the fall in the difference between filtered glutamine
and extracted glutamine observed in patients leads one to
suppose an augmented antiluminal transport of this substrate,
as observed in chronic metabolic acidosis [7]. The similarity of
renal release of glutamate and alanine between patients and
controls suggests that in patients renal metabolism of glutamine
has mainly used the deamination pathway [8]. Despite the
increased glutamine utilization by the kidney observed in
patients, blood levels of glutamine are unchanged. Thus, an
increased production of glutamine by peripheral tissues and/or
a declined use of it by splanchnic organs must take place.
Taken together, these data demonstrate that in patients with
CPD renal ammoniagenesis somewhat reproduces the pattern
observed in humans with chronic metabolic acidosis.
Distribution of produced ammonia between urine and renal
venous blood
The distribution of produced ammonia between urine and
renal venous blood is crucial for the regulation of systemic
acid-base balance in as much as only NH4 excretion in urine
corresponds to a net bicarbonate gain [8]. In patients with CPD
reported here, synthesized ammonia is distributed almost
equally between urine and renal venous blood, similarly to what
is observed in controls, despite the higher urine pH observed in
patients. A similar finding has been also observed in rats with
CPD [29]. This pattern of distribution is consistent with the
observation that in CPD a substantial ammonia excretion is
associated with a relatively high urine pH [11,
Both in the normal condition and metabolic acid-base distur-
bances the distal acidification process is the major factor
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responsible for the distribution of ammonia between urine and
blood [8]. In subjects with metabolic acidosis of different
duration [7, 17, 40] and with acute metabolic alkalosis [41] the
ratio of urinary ammonia to total ammonia production is corre-
lated with urine pH [7, 17, 40, 41]; this finding in agreement with
the well-known inverse correlation between urinary ammonia
excretion and urine pH [5]. In addition, when metabolic acid-
base disorders were considered together, it was observed that
in humans the ratio of urinary ammonia excretion to total
ammonia production showed a highly significant, inverse, non-
linear correlation with urine pH [42]. Furthermore, stepwise
multiple regression analysis has demonstrated that urine pH has
a preeminent role in the partition of produced ammonia be-
tween urine and blood, whereas total ammonia production,
RBF, and urine flow have a minor but significant role [42].
These factors together explain more than 90% of variations
observed in intrarenal ammonia partition [42].
In CPD, at variance with metabolic acid-base disturbances,
an only slight, if even significant inverse nonlinear correlation
between the ratio of urinary ammonia to total ammonia produc-
tion and urine pH has been detected (Fig. 2). Furthermore,
multiple regression analysis demonstrates that urine pH has
only a minor role in ammonia partition, while RBF assumes a
major part, and urine flow maintains a small, yet significant,
role in metabolic acid-base disturbances. The fact that urine
flow is a significant predictor in the multiple regression analysis,
but not in the simple regression analysis, implies that, when the
contribution of the other determinants to ammonia partition is
excluded, urine flow explains a significant fraction of the
remaining variations in the partition. It is noteworthy that in
CPD all the mentioned factors explain only about 40% of the
variations detected in ammonia partition. Consequently, other
mechanisms in addition to those considered must intervene in
the partition of ammonia between urine and blood.
A key question is why does urine pH in CPD lose its major
role in ammonia partition and, at the same time, why is urine
pH relatively high with respect to ammonia excretion. A
defective ability to generate a normal transepithelial proton
gradient has been claimed [1]. Alternatively, a discrepancy
between medullary ammonia concentration and distal proton
secretion can be supposed. If proton secretion in the collecting
ducts is secretory limited, urinary ammonia becomes an impor-
tant determinant of urine pH [43]. This possibility may occur in
potassium depletion if an augmented NH3 diffusion from the
medullary interstitium is associated with a relatively low proton
secretion into the lumen of collecting ducts. Indeed, in the
present study the greatest part of variations in intrarenal
ammonia distribution is unexplained by the measured determi-
nants responsible for ammonia partition in metabolic acid-base
disturbances (Table 3). It has been recently demonstrated by
microperfusion studies that low potassium levels in tubular
perfusate enhance NH4 absorption across the thick ascending
limb [13]. It may be inferred that an increase in medullary
ammonia concentration might ensue in the intact animal. Inter-
estingly, ammonia levels in renal venous blood, an index of
ammonia levels in cortical interstitium [44], are increased in
patients with CPD. Accordingly, one can hypothesize that in
this clinical setting the exaggerated ammonia accumulation in
the medullary interstitium caused by potassium depletion,
floods renal cortex and becomes a major factor responsible for
ammonia partition between urine and renal venous blood.
Consequences of changes in renal ammonia metabolism
Because only the aliquot of NH4 excreted with urine elicits
a stoichiometric net gain of bicarbonate [8], in patients with
CPD the increased ammonia production is somewhat blunted
with regard to the effects on acid-base status by the almost
equal distribution between urine and blood. Nevertheless, in
absolute terms, owing to the increased ammoniagenesis, net
bicarbonate gain is increased twofold in patients relatively to
controls, thereby contributing to the maintenance of metabolic
alkalosis.
CPD both in humans and experimental animals is associated
with tubulointerstitial lesions, renal enlargement, and a defect
in the ability to concentrate the urine [29, 45—47]. These
alterations have been in part attributed to the increased intra-
renal levels of ammonia [29, 46—48]. Results obtained in the
present study are noteworthy because they strongly suggest
that in patients with CPD, ammonia levels increase abnormally
in renal tissue, owing to the lack of a preferential diversion of
ammonia into the urine in the presence of an increased ammo-
nia production.
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